News archive

The Ministry of Social Affairs has decided to allocate 4.9 million SEK to the innovation project BrAInChild, as part of the larger initiative within Genomic Medicine Sweden (GMS). BrAInChild aims to develop and implement advanced precision diagnostics for children with cancer, potentially leading to more individualized and effective treatments.

The KI Biobank in Solna turns 20 this year. No fewer than 8.5 million samples from 750,000 individuals are preserved in its freezers. “The biobank is absolutely crucial to meeting tomorrow’s research needs,” says Sanela Kjellqvist, head of the KI Biobank.

The Swedish Childhood Tumor Biobank is a nationally established genomic biobank infrastructure in the field of childhood cancer that works to promote research on childhood tumors. Within the Genomic Medicine Sweden (GMS) Child Cancer project, the Swedish Childhood Tumor Biobank at KI and the Department of Oncology-Pathology receive SEK 5.13 million from the government.

A new Swedish biobank act comes into force on July 1. It is expected to make it easier for researchers to use biobanks – i.e. collections of samples of human and fetal tissue – and to collaborate.

The group of expert coordinators at the Centre for Health Crises keeps growing. The expert coordinators manage the work that is done within their field of expertise. The latest area of expertise to be added to the Centre is laboratory and diagnostic preparedness, with Jessica Alm as expert coordinator.

Doctoral student Anthony Larsson will defend his doctoral thesis on 12 December 2018 at Karolinska Institutet. The thesis covers the fate of biobank initiative BBMRI.se, which was ultimately discontinued by the Swedish Research Council following an investigation. In his thesis, Anthony Larsson describes why the initiative failed. However, his work began on completely different premises.